Clinical efficacy of CT-guided iodine-125 seed brachytherapy in unresectable locoregionally recurrent breast cancer [0.03%]
CT引导下碘-125粒子植入术治疗不可手术的局部区域复发性乳腺癌的临床疗效
Liqiu Ji,Wenwen Zhang,Shanhu Hao et al.
Liqiu Ji et al.
Purpose: Clinical efficacy of computed tomography (CT)-guided iodine-125 (125I) seed brachytherapy in unresectable locoregionally recurrent breast cancer. ...
Quality improvement methodology implementation for timely MRI-based brachytherapy treatment delivery in watch-and-wait expectant rectal cancer patients [0.03%]
改善基于MRI的近距离治疗的及时递送以观察等待期待直肠癌患者中的质量改进方法学实施
Rahul Krishnatry,Akshay Dinesan,Manideep Peddi et al.
Rahul Krishnatry et al.
Purpose: Long-course chemoradiation followed by a brachytherapy boost is one of the acceptable treatment options for watch-and-wait (W&W) eligible rectal cancer patients. However, MRI acquisition, planning, and treatment ...
Safety and efficacy of iridium-192 high-dose-rate interstitial brachytherapy for pleural and chest wall tumours: preliminary results [0.03%]
用于胸膜和胸部肿瘤的铱-192高剂量率组织间植入内照射治疗的安全性及疗效：初步结果报告
Jing Zhang,Bin Chen,Sheng Lin et al.
Jing Zhang et al.
Purpose: To evaluate the safety and efficacy of computed tomography (CT)-guided iridium-192 (192Ir) high-dose-rate (HDR) interstitial brachytherapy (ISBT) for pleural and chest wall malignant tumours. ...
Predictors of interstitial brachytherapy utilization in locally advanced cervical cancer and impact on overall survival [0.03%]
局部晚期宫颈癌间质内放疗的影响因素及其对总体生存率的影响
May Elbanna,Namita Agrawal,Jordan A Holmes
May Elbanna
Purpose: For locally advanced cervical cancer (LACC), the addition of brachytherapy (BT) improves overall survival (OS), and interstitial BT has been prospectively shown to improve target and organ at risk dose. Brachythe...
A comparative cost-benefit analysis of electronic brachytherapy vs. high-dose-rate iridium-192 for exclusive vaginal cuff treatment in post-operative endometrial cancer [0.03%]
单纯阴道癌术后患者使用电子腔内治疗与高剂量锎-192粒子治疗的成本效益分析比较研究
Sergio Lozares-Cordero,Víctor González-Pérez,Marta Sánchez-Casi et al.
Sergio Lozares-Cordero et al.
Purpose: To compare the economic and dosimetric aspects of electronic brachytherapy (eBT) and high-dose-rate (HDR) iridium-192 (192Ir) brachytherapy for exclusive vaginal cuff treatment in post-operative endometrial cance...
The irreplaceable art of brachytherapy: A technical note on interstitial high-dose-rate interventional radiotherapy (brachytherapy) in eyelid tumors [0.03%]
不可替代的近距离治疗技术：眼睑肿瘤间质高剂量率介入放射治疗（后装治疗）的技术备注
Tanvir Pasha,Nikhila Radhakrishna,Sushma Poojar et al.
Tanvir Pasha et al.
Purpose: Eyelid tumors are uncommon malignancies, where 75% of cases are cutaneous basal cell carcinoma (BCC), and sebaceous cell carcinoma, squamous, adenocarcinoma from meibomian glands are diagnosed in 25%. Post-excisi...
Impact of patient transfer system on applicator stability and dosimetry in cervical cancer brachytherapy [0.03%]
宫颈癌后装治疗中患者转移系统对施源器稳定性及剂量学的影响分析
Jittima Junhong,Ekkasit Tharavichitkul,Anirut Watcharawipha et al.
Jittima Junhong et al.
Purpose: This study aimed to evaluate applicator displacement due to patient transfer using traditional fixation (TRD) with and without patient transfer system (TS), and to assess its dosimetric impact on organs at risk (...
Brachytherapy for eyelid cancers: Re-defining outcomes and esthetics in rare histologies [0.03%]
睑部癌症的近距离治疗：罕见组织学中的疗效和美容效果的新定义
Sarbani Ghosh Laskar,Anuj Kumar,Prashasti Sharma et al.
Sarbani Ghosh Laskar et al.
Purpose: To evaluate local control, cosmetic outcomes, toxicities, and survival outcomes of interstitial high-dose-rate (HDR) brachytherapy treatment in non-basal cell carcinoma malignancies of the eyelid. ...
Near-fatal saddle pulmonary embolism following chemoradiotherapy and brachytherapy for locally advanced cervical cancer: A case series [0.03%]
局部晚期宫颈癌患者接受化学放射治疗及后装治疗后发生致死性纵隔肿瘤栓塞的病例报告
Lisa Leijtens,Jurgen Piek,Marlijn Kamps et al.
Lisa Leijtens et al.
Purpose: Women with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapy are at increased risk of venous thromboembolic events. ...
Orchiepididymitis as a rare complication of TURP performed four weeks after high-dose-rate brachytherapy for prostate cancer [0.03%]
前列腺癌高剂量率组织间治疗后4周行经尿道前列腺切除术引起的罕见并发症——附睾炎性输精管炎报告1例
Justyna Rembak-Szynkiewicz,Patrycja Mazgaj,Tomasz Szopin&#x;ski et al.
Justyna Rembak-Szynkiewicz et al.
The aim of this paper was to present a rare complication of orchiepididymitis in a patient treated with brachytherapy (BT) for prostate cancer, who underwent trans-ureteral resection of the prostate (TURP) four weeks after BT. A 73-year-old...